ArticleFrontiers in oncology2026
Correlation between immune suppressor cells and cytokines in the peripheral blood of patients with chronic lymphocytic leukemia.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with chronic lymphocytic leukemia (CLL) exhibit elevated levels of various cytokines and increased numbers of immunosuppressive cell subpopulations. However, the relationship between cytokines and suppressor cells remains unclear. Studies in this field may contribute to a better understanding of the role of cytokines in the accumulation of suppressor cells. Methods: Serum levels of 47 cytokines in patients with CLL and healthy donors were measured using multiplex analysis. The numbers of suppressor cells, including mMDSCs, Tregs, CD14+/IDO+ monocytes, and gMDSCs in peripheral blood, were determined using flow cytometry. Results: A significant difference in the levels of 29 cytokines was observed between primary CLL patients and healthy donors. A statistically significant increase in the numbers of mMDSCs, Tregs, and CD14+/IDO+ monocytes was observed in CLL patients compared to healthy donors, while no significant differences were noted in the CD15+/LOX-1+gMDSCs numbers between CLL patients and healthy donors. Correlations were found between the levels of several cytokines and immunosuppressive cell numbers. Among these, two cytokines, MIP-1α and M-CSF, showed a positive correlation with two suppressor cell subpopulations. Furthermore, the levels of these cytokines differed between patients with Binet stage B and stage C CLL. Conclusions: Our findings suggest that these two cytokines play a key role in the immunosuppression observed in CLL patients. These results, demonstrating a correlation between cytokine levels and the numbers of suppressor cells in CLL patients, are consistent with our previous hypothesis. This hypothesis states that the simultaneous action of growth factors and pro-inflammatory cytokines can lead to immune system inhibition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.